Deregulation of NF-κB and its upstream kinases in cancer

Cancer and Metastasis Reviews

Volumn 22, Issue 4, 2003, Pages 405-422

  Sun, Shao Cong ^a   Xiao, Gutian ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer cell signaling; IKK; NF B; NF B activating kinases

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOTRANSFERASE;

APOPTOSIS; CANCER; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; HUMAN; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW; CELL DIVISION; CELL MOTION; GENE EXPRESSION REGULATION; METABOLISM; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION; TIME; VIROLOGY;

APOPTOSIS; CELL DIVISION; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; NF-KAPPA B; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 0038724819     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023733231406     Document Type: Review

References (213)

1. Karin M, Delhase M: The I kappa B kinase (IKK) and NF-kappa B: Key elements of proinflammatory signaling. Semin Immunol 12: 85-98, 2000
2. Silverman N, Maniatis T: NF-κB signaling pathways in mammalian and insect innate immunity. Genes & Dev 15: 2321-2342, 2001
3. Fan CM, Maniatis T: Generation of p50 subnit of NF-κB by processing of p105 through an ATP-dependent pathway. Nature 354: 395-398, 1991
4. Bαldwin AS Jr: The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683, 1996
5. Rice NR, MacKichan ML, Israel A: The precursor of NF-κB p50 has IκB-like functions. Cell 71: 243-253, 1992
6. Mercurio F, DiDonato JA, Rosette C, Karin M: p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev 7: 705-718, 1993
7. Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K, Siebenlist U: The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature 359: 339-342, 1992
8. Wulczyn FG, Naumann M, Scheidereit C: Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature 358: 597-599, 1992
9. Bours V, Franzoso G, Azarenko V, Park S, Kanno T, Brown K, Siebenlist U: The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 72: 729-739, 1993
10. Fujita T, Nolan GP, Liou HC, Scott ML, Bαltimore D: The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes & Dev 7: 1354-1363, 1993
11. Whiteside ST, Epinat JC, Rice NR, Israël A: I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J 16: 1413-1426, 1997
12. Solan NJ, Miyoshi H, Carmona EM, Bren GD, Paya CV: RelB cellular regulation and transcriptional activity are regulated by p100. J Biol Chem 277: 1405-1418, 2002
13. Pahl HL: Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18: 6853-6866, 1999
14. Rayet B, Gelinas C: Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18: 6938-6947, 1999
15. Bαldwin AS: Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 107: 241-246, 2001
16. Bαrgou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer HD, Scheidereit C, Dorken B: High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 87: 4340-4347, 1996
17. Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C: Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia 14: 399-402, 2000
18. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE: Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 100: 2952-2960, 1997
19. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJJ, Sledge GWJ: Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17: 3629-3639, 1997
20. Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, Moldawer LL, Copeland EMr, Mackay S: Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery 130: 363-369, 2001
21. Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ: Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 60: 5334-5339, 2000
22. Palayoor ST, Youmell MY, Calderwood SK, Coleman CN, Price BD: Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene 18: 7389-7394, 1999
23. Tai DI, Tsai SL, Chang YH, Huang SN, Chen TC, Chang KS, Liaw YF: Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 89: 2274-2281, 2000
24. Meyskens FLJ, Buckmeier JA, McNulty SE, Tohidian NB: Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress. Clin Cancer Res 5: 1197-1202, 1999
25. Yang J, Richmond A: Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells. Cancer Res 61: 4901-4909, 2001
26. Wang C-Y, Mayo MW, Bαldwin AS Jr: TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274: 784-787, 1996
27. Iwanaga M, Mori K, Iida T, Urata Y, Matsuo T, Yasunaga A, Shibata S, Kondo T: Nuclear factor kappa B dependent induction of gamma glutamylcysteine synthetase by ionizing radiation in T98G human glioblastoma cells. Free Radic Biol Med 24: 1256-1268, 1998
28. Bαrinaga M: Life-death balance within the cell. Science 274: 724, 1996
29. Kontgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D, Gerondakis S: Mice lacking the c-rel protooncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 15: 1965-1977, 1995
30. Caamano JH, Rizzo CA, Durham SK, Bαrton DS, Raventos-Suarez C, Snapper CM, Bravo R: Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med 187: 185-196, 1998
31. Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A, Grinberg A, Tran T, Scharton-Kersten T, Anver M, Love P, Brown K, Siebenlist U: Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med 187: 147-159, 1998
32. Karin M, B∈n-Neriah Y: Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663, 2000
33. Sun S-C, Ganchi PA, Bαllard DW, Greene WC: NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259: 1912-1915, 1993
34. Ling L, Cao Z, Goeddel DV: NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc Natl Acad Sci USA 95: 3792-3797, 1998
35. Delhase M, Hayakawa M, Chen Y, Karin M: Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284: 309-313, 1999
36. Ghosh S, Karin M: Missing pieces in the NF-κB puzzle. Cell 109: S81-S96, 2002
37. Xiao G, Harhaj EW, Sun SC: NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 7: 401-409, 2001
38. Senftleben U, Cao Y, Xiao G, Kraehn G, Greten F, Chen Y, Hu Y, Fong A, Sun S-C, Karin M: Activation of IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293: 1495-1499, 2001
39. Xiao G, Cvijic ME, Fong A, Harhaj EW, Uhlik MT, Waterfield M, Sun SC: Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: Evidence for the involvement of IKKα. EMBO J 20: 6805-6815, 2001
40. Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR: Distinct roles of the IκB kinase α and β subunits in liberating nuclear factor kappa B (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB. J Biol Chem 277: 3863-3869, 2002
41. Davis M, Hatzubai A, Andersen JS, B∈n-Shushan E, Fisher GZ, Yaron A, Bαuskin A, Mercurio F, Mann M, B∈n-Neriah Y: Pseudosubstrate regulation of the SCF(β-TrCP) ubiquitin ligase by hnRNP-U. Genes Dev 16: 439-451, 2002
42. Johnson C, Van Antwerp D, Hope TJ: An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα. EMBO J 18: 6682-6693, 1999
43. Rodriguez MS, Thompson J, Hay RT, Dargemont C: Nuclear retention of IκBα protects it from signal-induced degradation and inhibits nuclear factor κB transcriptional activation. J Biol Chem 274: 9108-9115, 1999
44. Huang TT. Kudo N, Yoshida M, Miyamoto S: A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes. Proc Natl Acad Sci USA 97: 1014-1019, 2000
45. Tam WF, Lee LH, Davis L, Sen R: Cytoplasmic sequestration of rel proteins by IκBα requires CRMl-dependent nuclear export. Mol Cell Biol 20: 2269-2284, 2000
46. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S: IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80: 573-582, 1995
47. Harhaj EW, Maggirwar SB, Good L, Sun S-C: CD28 mediates a potent costimulatory signal for rapid degradation of IκBβ which is associated with accelerated activation of various NF-κB/Rel heterodimers. Mol Cell Biol 16: 6736-6743, 1996
48. Harhaj EW, Maggirwar SB, Sun S-C: Inhibition of p105 processing by NF-κB proteins in transiently transfected cells. Oncogene 12: 2385-2392, 1996
49. Heissmeyer V, Krappmann D, Wulczyn FG, Scheidereit C: NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes. EMBO J 18: 4766-4778, 1999
50. Harhaj EW, Sun S-C: IκB kinases serve as a target of CD28 signaling. J Biol Chem 273: 25185-25190, 1998
51. Orian A, Gonen H, Bercovich B, Fajerman I, Eytan E, Israel A, Mercurio F, Iwai K, Schwartz AL, Ciechanover A: SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase. EMBO J 19: 2580-2591, 2000
52. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR: The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17: 525-535, 2002
53. Claudio E, Brown K, Park S, Wang H, Siebenlist U: BAFF-induced NEMO-independent processing of NF-kappaB2 in maturing B cells. Nat Immunol 3: 958-965, 2002
54. Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin J, Starovasnik MA, Dixit VM: BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17: 515-524, 2002
55. Coope HJ, Atkinson PG, Huhse B, B∈lich M, Janzen J, Holman MJ, Klaus GG, Johnston LH, Ley SC: CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J 15: 5375-5385, 2002
56. Naumann M, Scheidereit C: Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO J 13: 4597-4607, 1994
57. Zhong H, Voll RE, Ghosh S: Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1: 661-671, 1998
58. Wang D, Bαldwin ASJ: Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J Biol Chem 273: 29411-29416, 1998
59. Martin AG, Fresno M: Tumor necrosis factor-α activation of NF-κB requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel. J Biol Chem 275: 24383-24391, 2000
60. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S: The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-424, 1997
61. Norris JL, Bαldwin AJ: Oncogenic Ras enhances NF-kappaB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways. J Biol Chem 274: 13841-13846, 1999
62. Wang D, Westerheide SD, Hanson JL, Bαldwin AS Jr: Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J Biol Chem 275: 32592-32597, 2000
63. Anrather J, Csizmadia V, Soares MP, Winkler H: Regulation of NF-kappaB RelA phosphorylation and transcriptional activity by p21(ras) and protein kinase Czeta in primary endothelial cells. J Biol Chem 274: 13594-13603, 1999
64. Leitges M, Sanz L, Martin P, Duran A, Braun U, Garcia JF, Camaccho F, Diaz-Meco MT, Rennert PD, Moscat J: Targeted disruption of the ζ-PKC gene results in the impairment of the NF-κB pathway. Mol Cell 8: 771-780, 2001
65. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W: IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274: 30353-30356, 1999
66. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR: Requirement for glycogen synthase kinase-3beta in cell survival and NF-κB activation. Nature 406: 86-90, 2000
67. Bonnard M, Mirtsos C, Suzuki S, Graham K, Juang J, Ng M, Itie A, Wakeham A, Shahinian A, Henzel WJ: Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-κB-dependent gene transcription. EMBO J 19: 4976-4985, 2000
68. Yin L, Wu L, Wesche H, Arthur CD, White JM, Goeddel DV, Schreiber RD: Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 291: 2162-2165, 2001
69. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Bαldwin AS Jr: Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Mol Cell Biol 20: 1626-1638, 2000
70. Sizemore N, Leung S, Stark GR: Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit. Mol Cell Biol 19: 4798-4805, 1999
71. Madrid LV, Mayo MW, Reuther JY, Bαldwin AS Jr: Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 276: 18934-18940, 2001
72. Lee FS, Hagler J, Chen ZJ, Maniatis T: Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88: 213-222, 1997
73. Malinin NL, Boldin MP, Kovalenko AV, Wallach D: MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385: 540-544, 1997
74. Bεlich MP, Salmeron A, Johnston LH, Ley SC: TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105. Nature 397: 363-368, 1999
75. Lin X, Cunningham ET, Mu Y, Geleziunas R, Greene WC: The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases. Immunity 10: 271-280, 1999
76. Yang J, Lin Y, Guo Z, Cheng J, Huang J, Deng L, Liao W, Chen Z, Liu Z, Su B: The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol 2: 620-624, 2001
77. Lallena M-J, Diaz-Meco MT, Bren G, Paya CV, Moscat J: Activation of IκB kinase β by protein kinase C isoforms. Mol Cell Biol 19: 2180-2188, 1999
78. Coudronniere N, Villalba M, Englund N, Airman A: NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc Natl Acad Sci USA 97: 3394-3399, 2000
79. Lin X, O'Mahony A, Mu Y, Geleziunas R, Greene WC: Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta. Mol Cell Biol 20: 2933-2940, 2000
80. Khoshnan A, Bαe D, Tindell CA, Nel AE: The physical association of protein kinase C with a lipid raft-associated inhibitor of kappa B factor kinase (IKK) complex plays a role in the activation of the NF-kappa B cascade by TCR and CD28. J Immunol 165: 6933-6940, 2000
81. Saijo K, Mecklenbrauker I, Santana A, Leitger M, Schmedt C, Tarakhovsky A: Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha. J Exp Med 195: 1647-1652, 2002
82. Krappmann D, Parke A, Heissmeyer V, Scheidereit C: B-cell receptor- and phorbol ester-induced NF-kappaB and c-Jun N-terminal kinase activation in B cells requires novel protein kinase C's. Mol Cell Biol 21: 6640-6650, 2001
83. Castrillo A, Pennington DJ, Otto F, Parker PJ, Owen MJ, Bosca L: Protein kinase Cepsilon is required for macrophage activation and defense against bacterial infection. J Exp Med 194: 1231-1242, 2001
84. Sun Z, Arendt CW, Ellmeier W, Schaeffer EM, Sunshine MJ, Gandhi L, Annes J, Petrzilka D, Kupfer A, Schwartzberg PL, Littman DR: PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404: 402-407, 2000
85. Su TT, Guo B, Kawakami Y, Sommer K, Chae K, Humphries LA, Kato RM, Kang S, Patrone L, Wall R, Teitell M, Leitges M, Kawakami T, Rawlings DJ: PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol 3: 780-786, 2002
86. Ruland J, Duncan GS, Elia A, del Bαrco Bαrrantes I, Nguyen L, Plyte S, Millar DG, Bouchard D, Wakeham A, Ohashi PS, Mak TW: Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 104: 33-42, 2001
87. Gaide O, Martinon F, Micheau O, Bonnet D, Thome M, Tschopp J: Carmal, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation. FEBS Lett 496: 121-127, 2001
88. McAllister-Lucas LM, Inohara N, Lucas PC, Ruland J, Benito A, Li Q, Chen S, Chen FF, Yamaoka S, Verma IM, Mak TW, Nunez G: Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J Biol Chem 276: 30589-30597, 2001
89. Gaide O, Favier B, Legler DF, Bonnet D, Brissoni B, Valitutti S, Bron C, Tschopp J, Thome M: CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation. Nat Immunol 3: 836-843, 2002
90. Wang D, You Y, Case SM, McAllister-Lucas LM, Wang L, DiStefano PS, Nunez G, Bertin J, Lin X: A requirement for CARMA1 in TCR-induced NF-kappa B activation. Nat Immunol 3: 830-835, 2002
91. Bεrtin J, Guo Y, Wang L, Srinivasula SM, Jacobson MD, Poyet JL, Merriam S, Du MQ, Dyer MJ, Robison KE, DiStefano PS, Alnemri ES: CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B. J Biol Chem 275: 41082-41086, 2000
92. Bεrtin J, Wang L, Guo Y, Jacobson MD, Poyet JL, Srinivasula SM, Merriam S, DiStefano PS, Alnemri ES: CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B. J Biol Chem 276: 11877-11882, 2001
93. Arch RH, Gedrich RW, Thompson CB: Tumor necrosis factor receptor-associated factors (TRAFs)-a family of adaptor proteins that regulates life and death. Genes & Dev 12: 2821-2830, 1998
94. Wajant H, Henkler F, Scheurich P: The TNF-receptor-associated factor family: Scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 13: 389-400, 2002
95. Bαud V, Liu ZG, Bennett B, Suzuki N, Xia Y, Karin M: Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an aminoterminal effector domain. Genes & Dev 13: 1297-1308, 1999
96. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kaufman S, van der Heiden A, Itie A, Wakeham A, Khoo W, Sasaki T, Cao Z, Penninger JM, Paige CJ, Lacey DL, Dunstan CR, Boyle WJ, Goeddel DV, Mak TW: TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40 and LPS signaling. Genes & Dev 13: 1015-1024, 1999
97. Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, Takatsu K, Nakao K, Nakamura K, Katsuki M, Yamamoto T, Inoue J: Severe osteopetrosis, defective interleukin-1 signaling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4: 353-362, 1999
98. Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ: Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiqutitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361, 2000
99. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J-I, Chen ZJ: TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: 346-351, 2001
100. Horie R, Watanabe T, Ito K, Morisita Y, Watanabe M, Ishida T, Higashihara M, Kadin M, Watanabe T: Cytoplasmic aggregation of TRA F2 and TRAF5 proteins in the Hodgkin-Reed-Sternberg cells. Am J Pathol 160: 1647-1654, 2002
101. Cahir McFarland ED, Izumi KM, Mosialos G: Epstein-barr virus transformation: Involvement of latent membrane protein 1-mediated activation of NF-kappaB. Oncogene 18: 6959-6964, 1999
102. Gilmore TD: Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene 18: 6925-6937, 1999
103. Carrasco D, Rizzo CA, Dorfman D, Brave R: The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice. EMBO J 15: 3640-3650, 1996
104. Gilmore TD, Cormier C, Jean-Jacques J, Gapuzan ME: Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene 20: 7098-7103, 2001
105. Staudt LM: The molecular and cellular origins of Hodgkin's disease. J Exp Med 191: 207-212, 2000
106. Wood KM, Roff M, Hay RT: Defective IkappaBαlpha in Hodgkin cell lines with constitutively active NF-kappaB. Oncogene 16: 2131-2139, 1998
107. Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT: Mutations in the IκBα gene in Hodgkin's disease suggest a tumor suppressor role for IkappaBαlpha. Oncogene 18: 3063-3070, 1999
108. Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F, Mathas S, Krappmann D, Scheidereit C, Stein H, Dorken B: Overexpression of 1 kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood 94: 3129-3134, 1999
109. Jungnickel B, Staratschek-Jox A, Brauninger A, Spieker T, Wolf J, Diehl V, Hansmann ML, Rajewsky K, Kuppers R: Clonal deleterious mutations in the IkappaBαlpha gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 191: 395-402, 1999
110. Bαrgou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dorken B: Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100: 2961-2969, 1997
111. Ishikawa H, Claudio E, Dambach D, Raventos-Suarez C, Ryan C, Bravo R: Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-κB1) but expressing p50. J Exp Med 187: 985-996, 1998
112. Cogswell PC, Guttridge DC, Funkhouser WK, Bαldwin JAS: Selective activation of NF-kappa B subunits in human breast cancer: Potential roles for NF-kappa B2/p52 and for Bcl-30. Oncogene 19: 1123-1131, 2000
113. Wang Y, Cui H, Schroering A, Ding JL, Lane WS, McGill G, Fisher DE, Ding H-F: NF-κB2 p100 is a pro-apoptotic protein with anti-oncogenic function. Nature Cell Biol in press:, 2002
114. McKeithan TW, Takimoto GS, Ohno H, Bjorling VS, Morgan R, Hecht BK, Dube I, Sandberg AA, Rowley JD: BCL3 rearrangements and t(14:19) in chronic lymphocytic leukemia and other B-cell malignancies: A molecular and cytogenetic study. Genes Chromosomes Cancer 20: 64-72, 1997
115. Ong ST, Hackbarth ML, Degenstein LC, Bαunoch DA, Anastasi J, McKeithan TW: Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice. Oncogene 16: 2333-2343, 1998
116. Shet AS, Jahagirdar BN, Verfaillie CM: Chronic myelogenous leukemia: Mechanisms underlying disease progression. Leukemia 16: 1402-1411, 2002
117. Kurzrock R, Gutterman JU, Talpaz M: The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 319: 990-998, 1988
118. Hamdane M, David-Cordonnier MH, D'Halluin JC: Activation of p65 NF-kappaB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB). Oncogene 15: 2267-2275, 1997
119. Reuther JY, Reuther GW, Cortez D, Pendergast AM, Bαldwin ASJ: A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation. Genes Dev 12: 968-981, 1998
120. Korus M, Mahon GM, Cheng L, Whitehead IP: p38 MAPK-mediated activation of NF-kappaB by the Rho-GEF domain of Bcr. Oncogene 21: 4601-4612, 2002
121. Willis TG, Jadayel DM, Du MQ, Peng H, Perry AR, Abdul-Rauf M, Price H, Karran L, Majekodunmi O, Wlodarska I, Pan L, Crook T, Hamoudi R, Isaacson PC, Dyer MJ: Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96: 35-45, 1999
122. Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L, Rakestraw KM, Naeve CW, Beckmann G, Weisenburger DD, Sanger WG, Nowotny H, Vesely M, Callet-Bαuchu E, Salles G, Dixit VM, Rosenthal A, Schlegelberger B, Morris SW: Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 22: 63-68, 1999
123. Costanzo A, Guiet C, Vito P: c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB. J Biol Chem 274: 20127-20132, 1999
124. Koseki T, Inohara N, Chen S, Carrio R, Merino J, Hottiger MO, Nabel GJ, Nunez G: CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10. J Biol Chem 274: 9955-9961, 1999
125. Srinivasula SM, Ahmad M, Lin JH, Poyet JL, Fernandes-Alnemri T, Tsichlis PN, Alnemri ES: CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis. J Biol Chem 274: 17946-17954, 1999
126. Thome M, Martinon F, Hofmann K, Rubio V, Steiner V, Schneider P, Mattmann C, Tschopp J: Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinase. J Biol Chem 274: 9962-9968, 1999
127. Yan M, Lee J, Schilbach S, Goddard A, Dixit V: mE10, a novel caspase recruitment domain-containing proapoptotic molecule. J Biol Chem 274: 10287-10292, 1999
128. Akagi T, Motegi M, Tamura A, Suzuki R, Hosokawa Y, Suzuki H, Ota H, Nakamura S, Morishima Y, Taniwaki M, Seto M: A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 18: 5785-5794, 1999
129. Dierlamm J, Bαens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK, De Wolf-Peeters C, Hagemeijer A, Van den Bεrghe H, Marynen P: The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21)p6ssociated with mucosa-associated lymphoid tissue lymphomas. Blood 93: 3601-3609, 1999
130. Morgan JA, Yin Y, Borowsky AD, Kuo F, Nourmand N, Koontz JI, Reynolds C, Soreng L, Griffin CA, Graeme-Cook F, Harris NL, Weisenburger D, Pinkus GS, Fletcher JA, Sklar J: Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res 59: 6205-6213, 1999
131. Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, Koonin EV, Dixit VM: Identification of paracaspases and metacaspases: Two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell 6: 961-967, 2000
132. Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, Chen FF, Yamaoka S, Seto M, Nunez G: Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 276: 19012-19019, 2001
133. Bos JL: ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689, 1989
134. Ellis CA, Clark G: The importance of being K-Ras. Cell Signal 12: 425-434, 2000
135. Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Bαldwin AJ: Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J Biol Chem 272: 24113-24116, 1997
136. Arsura M, Mercurio F, Oliver AL, Thorgeirsson SS, Sonenshein GE: Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. Mol Cell Biol 20: 5381-5391, 2000
137. Wang D, Richmond A: Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKKI/p38 mitogen-activated protein kinase pathway. J Biol Chem 276: 3650-3659, 2001
138. Kim BY, Gaynor RB, Song K, Dritschilo A, Jung M: Constitutive activation of NF-kappaB in Ki-ras-transformed prostate epithelial cells. Oncogene 21: 4490-4497, 2002
139. Mayo MW, Wang C-Y, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Bαldwin Jr. AS: Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278: 1812-1815, 1997
140. Sun S-C, Bαllard DW: Persistent activation of NF-κB by the Tax transforming protein of HTLV-1: hijacking cellular 1κB kinases. Oncogene 18: 6948-6958, 1999
141. Hiscott J, Kwon H, Genin P: Hostile takeovers: Viral appropriation of the NF-kappaB pathway. J Clin Invest 107: 143-151, 2001
142. Poiesz BF, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of a type C retrovirus particles from fresh cultured lymphocytes of a pateint with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415-7419, 1980
143. Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79: 2031-2035, 1982
144. Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham ET Jr, Grant M, Connelly MA, Hambor JE, Marcu KB, Greene WC: Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the lκB kinase α (IKKα) and IKKβ cellular kinases. Mol Cell Biol 18: 5157-5165, 1998
145. Uhlik M, Good L, Xiao G, Harhaj EW, Zandi E, Karin M, Sun S-C: NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation. J Biol Chem 273: 21132-21136, 1998
146. Yin M-J, Christerson LB, Yamamoto Y, Kwak Y-T, Xu S, Mercurio F, Bαrbose M, Cobb MH, Gaynor RB: HTLV-I Tax protein binds to MEKKI to stimulate IκB kinase activity and NF-κB activation. Cell 93: 875-884, 1998
147. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ, Israel A: Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 93: 1231-1240, 1998
148. Harhaj EW, Good L, Xiao G-T, Uhlik M, Cvijic ME, Rivera I, Sun S-C: Somatic mutagenesis studies of NF-kappa B signaling in human T cells: Evidence for an essential role of IKK gamma in NF-kappa B activation by T-cell costimulatory signals and HTLV-I Tax protein. Oncogene 19: 1386-1391, 2000
149. Chu Z-L, Shin Y-A, Yang J-M, DiDonato JA, Bαllard DW: IKKγ mediates the interaction of cellular IκB kinases with the Tax transforming protein of human T cell leukemia virus type I. J Biol Chem 274: 15297-15300, 1999
150. Harhaj EW, Sun S-C: IKKγ serves as a docking subunit of the IκB kinase and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J Biol Chem 274: 22911-22914, 1999
151. Jin D-Y, Giordano V, Kibler KV, Nakano H, Jeang K-T: Role of adaptor function in oncoprotein-mediated activation of NF-κB: HTLV-I Tax interacts directly with IκB kinase γ. J Biol Chem 274: 17402-17405, 1999
152. Xiao G, Harhaj EW, Sun S-C: Domain-specific interaction with IKKγ is an essential step in Tax-mediated activation of IKK. J Biol Chem 275: 34060-34067, 2000
153. Xiao G, Sun SC: Activation of IKKalpha and IKKbeta through their fusion with HTLV-1 tax protein. Oncogene 19: 5198-5203, 2000
154. Jin DY, Jeang KT: HTLV-I Tax self-association in optimal trans-activation function. Nucl Acids Res 25: 379-387, 1997
155. Kieff E: Epstein-Bαrr virus-increasing evidence of a link to carcinoma. N Engl J Med 333: 724-726. 1995
156. Rickinson AB, Kieff E Epstein-Bαrr Virus. In: KDHP Fields BN, eds. Virology, pp. 2397-2446. New York: Raven Press, 1996.
157. Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of bcl-2 expression by Epstein-Bαrr
158. Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM: The Epstein-Bαrr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem 267: 24157-24160, 1992
159. Wang S, Rowe M, Lundgren E: Expression of the Epstein Bαrr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res 56: 4610-4613, 1996
160. D'Souza B, Rowe M, Walls D: The bfl-1 gene is transcriptionally upregulated by the Epstein-Bαrr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line. J Virol 74: 6652-6658, 2000
161. Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G: Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Bαrr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-kappaB activation. Mol Cell Biol 16: 7098-7108, 1996
162. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E: The Epstein-Bαrr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80: 389-399, 1995
163. Devergne O, Cahir McFarland ED, Mosialos G, Izumi KM, Ware CF, Kieff E: Role of the TRAF binding site and NF-kappaB activation in Epstein-Bαrr virus latent membrane protein 1-induced cell gene expression. J Virol 72: 7900-7908, 1998
164. Schultheiss U, Puschner S, Kremmer E, Mak TW, Engelmann H, Hammerschmidt W, Kieser A: TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1. EMBO J 20: 5678-5691, 2001
165. He Z, Xin B, Yang X, Chan C, Cao L: Nuclear factor-κB activation is involved in LMP1-mediated transformation and tumorigenesis of rat-1 fibroblasts. Cancer Res 60: 1845-1848, 2000
166. Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E: NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Bαrr virus-transformed lymphoblastoid cells. Proc Natl Acad Sci USA 97: 6055-6060, 2000
167. Feuillard J, Schuhmacher M, Kohanna S, Asso-Bonnet M, Ledeur F, Joubert-Caron R, Bissieres P, Polack A, Bornkamm GW, Raphael M: Inducible loss of NF-κB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Bαrr virus-transformed B lymphocytes. Blood 95: 2068-2075, 2000
168. Beasley RP, Lin CC, Hwang LY, Chien CS: Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 2: 1129-1133, 1981
169. Diao J, Garces R, Richardson CD: X protein of heptitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 12: 189-205, 2001
170. Kekulé AS, Lauer U, Weiss L, Luber B, Hofschneider PH: Hepatitis B virus transactivator HBx uses a tumor promoter signaling pathway. Nature 361: 742-745, 1993
171. Wei R, Sirma H, Giannini C, Kremsdoft D, Bessia C, Dargemont C, Brechot C, Israel A: Direct association and nuclear import of the hepatitis B virus X protein with the NF-κB inhibitor IκBaα. Mol Cell Biol 19: 6345-6354, 1999
172. Meyer M, Caselmann WH, Schluter V, Schreck R, Hofschneider PH, Bαeuerle PA: Hepatitis B virus transactivator MHBst: Activation of NF-κB, selective inhibition by antioxidants and integral membrane localization. EMBO J 11: 2991-3001, 1992
173. Kekule AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R: The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343: 457-461, 1990
174. Hildt E, Saher G, Bruss V, Hofschneider PH: The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 225: 235-239, 1996
175. Hildt E, Munz B, Saber G, Reifenberg K, Hofschneider PH: The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J 21: 525-535, 2002
176. Dhawan P, Richmond A: A novel NF-κB-inducing kinase-MAPK signaling pathway up-regulates NF-κB activity in melanoma cells. J Biol Chem 277: 7920-7928, 2002
177. Sourvinos G, Tsatsanis C, Spandidos DA: Overexpression of the Tpl-2/Cot oncogene in human breast cancer. Oncogene 18: 4968-4973, 1999
178. Miyoshi J, Higashi T, Mukai H, Ohuchi T, Kakunaga T: Structure and transforming potential of the human cot oncogene encoding a putative protein kinase. Mol Cell Biol 11: 4088-4096, 1991
179. Patriotis C, Makris A, Bεar SE, Tsichlis PN: Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progress of rodent T-cell lymphomas and in T-cell activation. Proc Natl Acad Sci USA 90: 2251-2255, 1993
180. Makris A, Patriotis C, Bεar SE, Tsichlis PN: Genomic organization and expression of Tpl-2 in normal cells and Moloney routine leukemia virus-induced rat T-cell lymphomas: Activation by provirus insertion. J Virol 67: 4283-4289, 1993
181. Ceci JD, Patriotis CP, Tsatsanis C, Makris AM, Kovatch R, Swing DA, Jenkins NA, Tsichlis PN, Copeland NG: Tpl-2 is an oncogenic kinase that is activated by carboxyterminal trunction. Genes Dev 11: 688-700, 1997
182. Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE: Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 20: 1287-1299, 2001
183. Vale T, Ngo TT, White MA, Lipsky PE: Raf-induced transformation requires an interleukin I autocrine loop. Cancer Res 61: 602-607, 2001
184. Arlt A, Vorndamm J, Muerkoster S, Yu H, Schmidt WE, Folsch UR, Schafer H: Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines. Cancer Res 62: 910-916, 2002
185. Skinnider BF, Kapp U, Mak TW: Interleukin 13: a growth factor in hodgkin lymphoma. Int Arch Allergy Immunol 126: 267-276, 2001
186. Skinnider BF, Kapp U, Mak TW: The role of interleukin 13 in classical Hodgkin lymphoma. Leuk Lymphoma 43: 1203-1210, 2002
187. Hagemann C, Blank JL: The ups and downs of MEK kinase interactions. Cell Signal 13: 863-875, 2001
188. Pomerantz JL, Bαltimore D: NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18: 6694-6704, 1999
189. Hehner SP, Hofmann TG, Ushmorov A, Dienz O, Wing-Lan Leung I, Lassam N, Scheidereit C, Droge W, Schmitz ML: Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex. Mol Cell Biol 20: 2556-2568, 2000
190. Bαumann B, Weber CK, Troppmair J, Whiteside S, Israel A, Rapp UR, Wirth T: Raf induces NF-kappaB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. Proc Natl Acad Sci USA 97: 4615-4620, 2000
191. Hsu H, Shu HB, Pan MG, Goeddel DV: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308, 1996
192. Hu WH, Johnson H, Shu HB: Activation of NF-kappaB by FADD, Casper, and caspase-8. J Biol Chem 275: 10838-10844, 2000
193. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV: TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4: 387-396, 1996
194. McCarthy JV, Ni J, Dixit VM: RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J Biol Chem 273: 16968-16975, 1998
195. Yu PW, Huang BC, Shen M, Quast J, Chan E, Xu X, Nolan GP, Payan DG, Luo Y: Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB. Curr Biol 9: 539-542, 1999
196. Chaudhary PM, Eby MT, Jasmin A, Kumar A, Liu L, Hood L: Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene 19: 4451-4460, 2000
197. Muzio M, Ni J, Feng P, Dixit VM: IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1signaling. Science 278: 1612-1615, 1997
198. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, Di Marco F, French L, Tschopp J: MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 273: 12203-12209, 1998
199. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O'Neill LA: Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413: 78-83, 2001
200. Horng T, Bαrton GM, Medzhitov R: TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2: 835-841, 2001
201. Cao Z, Henzel WJ, Gao X: IRAK: a kinase associated with the interleukin-1 receptor. Science 271: 1128-1131, 1996
202. Wesche H, Gao X, Li X, Kirschning CJ, Stark GR, Cao Z: IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem 274: 19403-19410, 1999
203. Li S, Strelow A, Fontana EJ, Wesche H: IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci USA 99: 5567-5572, 2002
204. Inohara N, Koseki T, del Peso L, Hu Y, Yee C, Chen S, Carrio R, Merino J, Liu D, Ni J, Nunez G: Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem 274: 14560-14567, 1999
205. Ogura Y, Inohara N, Bεnito A, Chen FF, Yamaoka S, Nunez G: Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276: 4812-4818, 2001
206. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB: NF-kappaB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85, 1999
207. Romashkova JA, Makarov SS: NF-kappaB is a target of AKT in anti-apoptotic PDGF signaling. Nature 401: 86-90, 1999
208. Perona R, Montaner S, Saniger L, Sanchez-Perez I, Bravo R, Lacal JC: Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev 11: 463-475, 1997
209. D'Acquisto F, Ghosh S: PACT and PKR: turning on NF-kappa B in the absence of virus. Sci STKE 89: RE1, 2001
210. Li X, Commane M, Nie H, Hua X, Chatterjee-Kishore M, Wald D, Haag M, Stark GR: Act1, an NF-kappa B-activating protein. Proc Natl Acad Sci USA 97: 10489-10493, 2000
211. Leonardi A, Chariot A, Claudio E, Cunningham K, Siebenlist U: ClKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc Natl Acad Sci USA 97: 10494-10499, 2000
212. Foryst-Ludwig A, Naumann M: p21-activated kinase 1 activates the nuclear factor kappa B (NF-kappa B)-inducing kinase-1kappa B kinases NF-kappa B pathway and proinflammatory cytokines in Helicobacter pylori infection. J Biol Chem 275: 39779-39785, 2000
213. Frost JA, Swantek JL, Stippec S, Yin MJ, Gaynor R, Cobb MH: Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1. J Biol Chem 275: 19693-19699, 2000